scholarly journals Effects of salmon calcitonin treatment on serum and synovial fluid bone formation and resorption markers in osteoporosis patients

2015 ◽  
Author(s):  
Hasan Atbinici
Keyword(s):  
Synovial Fluid ◽  
Bone Formation ◽  
Salmon Calcitonin ◽  
Calcitonin Treatment

Salmon Calcitonin and the Treatment of Acute Osteoporosis

2006 ◽  
Vol 00 (02) ◽  
Author(s):  
Harold N Rosen
Keyword(s):  
Vertebral Fracture ◽  
Bone Resorption ◽  
Bone Formation ◽  
Salmon Calcitonin ◽  
Analgesic Effect ◽  
Treatment Options ◽  
Vertebral Compression Fractures ◽  
Human Calcitonin ◽  
Older Individuals ◽  
Compression Fractures

There are many different treatment options for osteoporosis available to physicians. Most of these are designed to prevent and treat osteoporosis by inhibiting bone resorption and/or increasing bone formation. One group of patients with very specific needs is those with vertebral compression fractures especially in those whom the most commonly used treatment, bisphosphonate, is not well tolerated. Under these circumstances salmon calcitonin, a treatment that has known efficacy in reducing further vertebral fracture, an analgesic effect, and is known to be safe and well tolerated in older individuals, could be the answer.Salmon calcitonin is the most widely used of the calcitonins effective in humans. It has 40 times the affinity for osteoclasts as human calcitonin and is very effective at inhibiting bone resorption.1,2

Salmon calcitonin treatment by nasal spray in primary hyperparathyroidism

Bone ◽  
1991 ◽  
Vol 12 (5) ◽  
pp. 311-316 ◽  
Author(s):  
O. Tørring ◽  
E. Bucht ◽  
U. Sjöstedt ◽  
H.E. Sjöberg
Keyword(s):  
Primary Hyperparathyroidism ◽  
Nasal Spray ◽  
Salmon Calcitonin ◽  
Calcitonin Treatment

Evaluation of salmon calcitonin treatment in bone metastases from breast cancer-a controlled trial

Bone ◽  
1988 ◽  
Vol 9 (1) ◽  
pp. 45-51 ◽  
Author(s):  
C. Blomqvist ◽  
I. Elomaa ◽  
L. Porkka ◽  
S.L. Karonen ◽  
C. Lamberg-Allardt
Keyword(s):  
Breast Cancer ◽  
Bone Metastases ◽  
Salmon Calcitonin ◽  
Controlled Trial ◽  
Calcitonin Treatment

scholarly journals Deafness in Paget's diseases: effect of salmon calcitonin treatment.

BMJ ◽  
1975 ◽  
Vol 2 (5973) ◽  
pp. 726-726 ◽  
Author(s):  
P M Grimaldi ◽  
S M Mohamedally ◽  
N J Woodhouse
Keyword(s):  
Salmon Calcitonin ◽  
Calcitonin Treatment

Serum calcium and inorganic phosphorus levels of the freshwater snake Sinonatrix piscator (formerly Natrix piscator) in response to calcitonin treatment

1989 ◽  
Vol 67 (5) ◽  
pp. 1335-1337 ◽  
Author(s):  
Ajai K. Srivastav ◽  
Ladli Rani
Keyword(s):  
Medical Research ◽  
Serum Calcium ◽  
Salmon Calcitonin ◽  
Inorganic Phosphate ◽  
Research Council ◽  
Medical Research Council ◽  
Inorganic Phosphorus ◽  
Calcitonin Treatment ◽  
Phosphorus Levels

The effects of administration of salmon calcitonin (0.25 Medical Research Council mU/g body wt.) on serum calcium and inorganic phosphate levels were investigated in Sinonatrix piscator for 15 days. The treatment evoked progressive hypocalcemia (from day 1 to day 5) and hypophosphatemia (from day 1 to day 3). Thereafter, these responses decreased and normal levels were regained.

Sign in / Sign up

Export Citation Format

Share Document